Celia Morgan is a professor of psychopharmacology at the University of Exeter in the United Kingdom. She completed her undergraduate degree and Ph.D. at University College London (UCL) and completed a scholarship programme at Yale University. After competing her Ph.D., Professor Morgan worked at University of Melbourne as a visiting research fellow, returning to UCL for a fellowship and then Lectureship.

She joined University of Exeter as a Senior Lecturer in 2013 and was given a Chair in Psychopharmacology in 2015. Professor Morgan also holds an Honorary Readership at University College London. She is the academic lead for both the Exeter Translational Addiction Partnership (ETAP) and Ketamine for Reduction of Alcoholic Relapse (KARE).

‍